Repair of Nasal Valve Compromise
Customize your policy alerts
Sign up for mhn Policy CP.MP.210 alerts
Get alerted when Policy CP.MP.210 changes without checking for updates manually.
Monitor payer policy activity
Medical necessity guidelines for surgical and procedural repair of nasal valve compromise (NVC) for members of the health plan; defines covered indications, required preconditions, and procedures considered investigational or not supported.
No material clinical or coverage changes in this revision.
Coverage Criteria for Repair of Nasal Valve Compromise
Medically necessary repair of nasal valve compromise
Covered when ALL of the following are met:
This policy identifies several procedures for repair of nasal vestibular stenosis that do not have established safety and efficacy and therefore are not supported. Specifically, the policy lists radiofrequency ablation (VivAer®), absorbable lateral wall implants (Latera®), and nasal valve suspension surgery as procedures with insufficient evidence to be considered standard care for nasal valve compromise. The VivAer procedure is an office‑based, low‑dose radiofrequency technique intended to remodel intranasal soft tissues by creating controlled coagulation lesions that stiffen tissue as they heal, but available studies are limited in quality and do not clearly demonstrate objective improvements in nasal airflow. The Latera implant is an absorbable PLLA‑PDLA lateral wall support placed endonasally and designed to be replaced by a fibrous matrix over about 12–18 months; however, its safety and long‑term effectiveness remain inadequately established in the evidence base. Due to these limitations, the policy treats these approaches as investigational for repair of nasal vestibular stenosis.
Coverage is limited to procedures meeting the policy’s medical necessity criteria; procedures billed with CPT 30468 or 30469 are listed as not supporting coverage. CPT 30468 describes repair with subcutaneous/submucosal lateral wall implant(s) and corresponds to absorbable implant approaches such as Latera, while CPT 30469 describes low‑energy, temperature‑controlled radiofrequency subcutaneous/submucosal remodeling, corresponding to procedures like VivAer. The policy explicitly states that VivAer, absorbable implants, and nasal valve suspension surgery lack sufficient established safety and efficacy for repair of nasal vestibular stenosis and thus are not supported for coverage under this policy.
CPT Codes and Coding Guidance
| 30465 | Repair of nasal vestibular stenosis (e.g., spreader grafting, lateral nasal wall reconstruction) |
Provider Requirements and Prior Authorization
Prior Authorization and Coding
Prior authorization required for repair of nasal vestibular stenosis when coverage criteria are met. Ensure the request is coded to the supporting CPT and includes required clinical documentation (see documentation callout).
- Submit prior authorization referencing CPT 30465 when clinical criteria for repair of nasal vestibular stenosis are satisfied.
- Include clinical findings (internal or external valve collapse), response to Cottle maneuver or lateralization testing, and documentation of a trial of conservative therapy.
Conservative Therapy Required
A documented trial of conservative therapies is required and must be included with the prior authorization request. Examples of acceptable conservative treatments are provided below; duration and response should be noted.
- Trial of nasal cones (e.g., Max-Air Nose Cones®, Sinus Cones®) or external nasal dilator adhesive strips (e.g., Breathe Right®).
- Outpatient nocturnal trial of external stents or nasal dilators and/or a six-week trial of intranasal corticosteroids.
- Document duration and patient response to conservative measures in the chart and with the authorization request.
Required Clinical Documentation
Include objective and procedural findings to support medical necessity. At a minimum, document the type of valve compromise, results of Cottle maneuver or lateralization testing, and details of conservative therapy tried.
- Document internal valve collapse or compromise of the upper lateral cartilage, or external valve compromise from lower lateral cartilage collapse.
- Record positive response to the Cottle maneuver, Bachman’s maneuver, or lateralization testing (e.g., improved nasal airflow with manual lateralization or instrument simulation).
- Include NOSE score, nasal endoscopy or anterior rhinoscopy findings, and results of any nasal decongestant testing or objective airflow measures when available.
Unsupported CPT Codes — Denial Risk
Do not submit requests for repair of nasal valve compromise under CPT codes that do not support coverage; such requests may be denied.
Background
Nasal valve compromise (NVC) is a structural narrowing of the nasal passage that can produce symptomatic obstructed breathing. Clinically, NVC may result from internal valve collapse involving the upper lateral cartilage or external nasal valve compromise due to collapse of the lower lateral cartilage. Diagnosis relies on history and focused physical examination maneuvers (for example, the Cottle maneuver or manual lateralization of the upper lateral cartilage), symptom correlation, and exclusion of other causes of obstruction. The policy requires documentation that symptoms correlate with valve findings and persist despite conservative measures before considering surgical repair.
Definitions
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.